All sites C00-96,D32-33,D42-43,D45-47,D76 535 90.2 1.9 2.7 0.8 4.3
Mouth, pharynx C00-14 6 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 114 87.2 1.4 5.1 1.2 5.1
  Oesophagus C15 5 100.0 - - - -
  Stomach C16 13 92.2 1.6 3.1 1.6 1.6
  Small intestine C17 3 100.0 - - - -
  Colon C18 39 98.0 - 0.5 - 1.5
  Rectum, rectosigmoid C19-20 24 98.3 - - - 1.7
  Anus C21 1 100.0 - - - -
  Liver C22 7 77.8 5.6 8.3 2.8 5.6
  Gallbladder, bile ducts C23-24 3 42.9 - 21.4 - 35.7
  Pancreas C25 18 51.1 5.6 21.1 5.6 16.7
  Other digestive organs C26 1 50.0 - 25.0 - 25.0
Respiratory organs C30-39 59 69.7 8.8 8.4 1.3 11.8
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 56 68.5 9.3 9.0 1.4 11.8
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 19 100.0 - - - -
Skin, non-melanoma C44 27 100.0 - - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 178 99.4 - - 0.1 0.4
  Prostate C61 173 99.4 - - 0.1 0.5
  Testis C62 4 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 50 94.4 0.4 2.4 0.4 2.4
  Kidney C64 12 88.3 - 5.0 1.7 5.0
  Bladder and urinary tract2 C65-68 38 96.4 0.5 1.6 - 1.6
Eye C69 1 83.3 - 16.7 - -
Brain, central nervous system C70-72,D32-33,D42-43 15 85.5 - 6.6 1.3 6.6
Thyroid gland C73 5 91.3 8.7 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 9 72.3 2.1 12.8 - 12.8
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 42 75.4 6.2 0.5 3.3 14.7
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 21 99.1 - - - 0.9
  Malignant immunoproliferative diseases C88 1 50.0 25.0 - - 25.0
  Myeloma and other plasma cell tumors C90 6 51.7 6.9 3.4 6.9 31.0
  Leukaemia C91-95 8 52.4 23.8 - 7.1 16.7
  Myelodysplastic syndromes D46 2 20.0 - - - 80.0
  Myeloproliferaitive neoplasms D45,D47 1 - - - 28.6 71.4
Not included above
  Basal cell carcinoma of the skin 107 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.